Beckman Research Institute of the City of Hope


City of Hope is an academic cancer research and treatment organization that conducts clinical care, translational research and GMP biologics and cell-product manufacturing. The organization operates immunotherapy-focused clinical trials across a national network, develops adoptive cellular and antibody-based therapies (including CAR T, TIL and NK approaches), integrates genomics and multi-omics with data science for translational analytics, and maintains an FDA-regulated GMP manufacturing facility to support early-phase studies and investigator-initiated programs.

Industries

N/A

Beckman Research Institute of the City of Hope

Expertise Areas

  • Immunotherapy and immuno-oncology
  • Adoptive cell therapies and apheresis workflows
  • Clinical trial management and execution for early-phase studies
  • GMP biologics and cellular manufacturing
  • Show More (6)

Key Technologies

  • CAR T cell therapy
  • Tumor-infiltrating lymphocyte (TIL) therapy
  • Natural killer (NK) cell therapy
  • Bispecific antibody formats
  • Show More (11)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.